Women hospitalized with atrial fibrillation: Gender differences, trends and outcome from a 20-year registry in a Middle Eastern country (1991-2010)

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 975-980

  Salam, Amar M ^a,b   AlBinali, Hajar A ^a,b   Al Mulla, Abdul Wahid ^a,b   Asaad, Nidal ^a,b   Singh, Rajvir ^b   Al Qahtani, Awad ^a,b   Al Suwaidi, Jassim ^a,b  

^a HAMAD GENERAL HOSPITAL   (Qatar)

^b HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

Atrial fibrillation; Gender; Outcome; Trends; Women

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE REGISTRY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QATAR; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

ATRIAL FIBRILLATION; GENDER; OUTCOME; TRENDS; WOMEN;

ADULT; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QATAR; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885293375     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.10.041     Document Type: Article

References (44)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012;125(1): e2-220.
2. Piccini JP, Hammill BG, Sinner MF, et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes 2012;5(1):85-93.
3. Simmons A, Falbe J, Vacek J. Coronary artery disease in women: a review and update. Rev Cardiovasc Med 2011;12(2):e84-93.
4. Pilote L, Dasgupta K, Guru V, et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 2007;176(6):S1-S44.
5. Friberg J, Scharling H, Gadsboøll N, Truelsen T, Jensen GB. Copenhagen City Heart Study. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol 2004;94(7):889-94.
6. Wändell PE. Five-year mortality in men and women with atrial fibrillation. Scand J Prim Health Care 2001;19(2):112-6.
7. Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 2005;112(12): 1687-91.
8. Essebag V, Reynolds MR, Hadjis T, et al. Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med 2007;167(15):1648-53.
9. Dagres N, Nieuwlaat R, Vardas PE, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007;49(5): 572-7.
10. Rienstra M, Van Veldhuisen DJ, Hagens VE, et al. RACE Investigators. Genderrelated differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol 2005;46(7):1298-306.
11. Patel D, Mohanty P, Di Biase L, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 2010;7(2):167-72.
12. Roquer J, Rodríguez-Campello A, Gomis M, et al. Comparison of the impact of atrial fibrillation on the risk of early death after stroke in women versus men. J Neurol 2006;253(11):1484-9.
13. Forleo GB, Tondo C, De Luca L, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace 2007;9(8):613-20.
14. Maas AH, van der Schouw YT, Regitz-Zagrosek V, et al. Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease. Eur Heart J September 29 2011;32(11):1362-8.
15. Kerr CR, Humphries K. Gender-related differences in atrial fibrillation. J Am Coll Cardiol 2005;46(7):1307-8.
16. Michelena HI, Powell BD, Brady PA, Friedman PA, Ezekowitz MD. Gender in atrial fibrillation: ten years later. Gend Med 2010;7:206-17.
17. Volgman AS, Manankil MF, Mookherjee D, Trohman RG. Women with atrial fibrillation: greater risk, less attention. Gend Med 2009;6(3):419-32.
18. Gage BF, Boechler M, Doggette AL, et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in Medicare beneficiaries with chronic atrial fibrillation. Stroke 2000;31:822-7.
19. Brass LM, Krumholz HM, Scinto JM, Radford M. Warfarin use among patients with atrial fibrillation. Stroke 1997;28:2382-9.
20. El-Menyar A, Albinali HA, Bener A, Mohammed I, Al Suwaidi J. Prevalence and impact of diabetes mellitus in patients with acute myocardial infarction: a 10-year experience. Angiology 2010;60:683-8.
21. Al Suwaidi J, Al-Qahtani A, Asaad N, Al-Mulla AW, Singh R, Albinali HA. Comparison of women versus men hospitalized with heart failure (from a 20-year registry in a middle-eastern country 1991-2010). Am J Cardiol 2012;109(3):395-400.
22. Al Suwaidi J, Bener A, Behair S, Al Binali HA. Mortality due to acute myocardial infarction in Qatari women. Heart 2004;90(6):693-4.
23. Hadi AR, Al Suwaidi J, Bener A, Khinji A, Al Binali HA. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar. (1991-2001). Int J Cardiol 2005;102:249-54.
24. Suwaidi JA, Asaad N, Al-Qahtani A, Al-Mulla AW, Singh R, Albinali HA. Prevalence and outcome of Middle-eastern Arab and South Asian patients hospitalized with heart failure: insight from a 20-year registry in a Middle-eastern country (1991-2010). Acute Card Care 2012;14(2):81-9.
25. Salam AM. Rate control versus rhythm control for the management of atrial fibrillation: the verdict of the AFFIRM trial. Expert Opin Investig Drugs 2003;12(7): 1231-7.
26. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in the adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;53: e1-90.
27. Humphries KH, Kerr CR, Connolly SJ, et al. New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation 2001;103(19): 2365-70.
28. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-4.
29. Salam AM. Managing atrial fibrillation in older people: a comparison of two treatment strategies. J Am Geriatr Soc 2003;51(12):1806-7.
30. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998;352:1167-71.
31. Lip GY. Stroke in atrial fibrillation: epidemiology and thromboprophylaxis. J Thromb Haemost 2011;9(Suppl. 1):344-51.
32. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart 2001;86(3):284-8.
33. Kalra L, Yu G, Perez I, Lakhani A, Donaldson N. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness. BMJ 2000;320(7244):1236-9.
34. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 1999;131(12): 927-34.
35. Wheeldon NM, Tayler DI, Anagnostou E, Cook D, Wales C, Oakley GD. Screening for atrial fibrillation in primary care. Heart 1998;79(1):50-5.
36. [No authors listed]Stroke prevention in atrial fibrillation study. Final results. Circulation 1991;84:527-39.
37. Khairallah F, Ezzedine R, Ganz LI, London B, Saba S. Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001. Am J Cardiol 2004;94:500-4.
38. Stewart S, MacIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996. Eur Heart J 2001;22:693-701.
39. Wattigney WA, Mensah GA, Croft JB. Increased atrial fibrillation mortality: United States, 1980-1998. Am J Epidemiol 2002;155:819-26.
40. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991;22:983-8.
41. Wang TJ, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community. The Framingham Heart Study. JAMA 2003;290:1049-56.
42. Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW; on behalf of the Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. Stroke 1999;30:1223-9.
43. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114(2):119-25.
44. Miyasaka Y, Barnes ME, Bailey KR, et al. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol 2007;49(9):986-92.